The post ONDO Technical Analysis Mar 23 appeared on BitcoinEthereumNews.com. ONDO is approaching critical supports at the $0.25 level; the strong buyer zone aroundThe post ONDO Technical Analysis Mar 23 appeared on BitcoinEthereumNews.com. ONDO is approaching critical supports at the $0.25 level; the strong buyer zone around

ONDO Technical Analysis Mar 23

2026/03/23 11:59
4 min di lettura
Per feedback o dubbi su questo contenuto, contattateci all'indirizzo crypto.news@mexc.com.

ONDO is approaching critical supports at the $0.25 level; the strong buyer zone around $0.2325 could be tested, while downward momentum is weakening with RSI at 41.67. The rejection at $0.2598 in resistances is reinforcing the downtrend.

Current Price Position and Critical Levels

ONDO is positioned in a short-term downtrend at its current $0.25 price and trading below EMA20 ($0.26). With a 24-hour loss of 3.18%, the price squeezed in the $0.24-$0.26 range is giving a bearish Supertrend signal on the 1D timeframe. In multi-timeframe (MTF) analysis, 10 strong levels were identified: 2 supports/1 resistance on 1D, 1 support/3 resistances on 3D, and 1 support/3 resistance confluences on 1W. Volume remains at a moderate level of $26M, RSI at 41.67 not approaching oversold but indicating momentum loss. The price has moved away from the broader structure’s $0.3364 upside target and is exposed to $0.1286 downside risk; the overall downtrend carries liquidity hunt potential.

Support Levels: Buyer Zones

Primary Support

$0.2325 (Strength Score: 68/100): This level stands out as a major order block (OB) on the 1W timeframe and has been tested 4 times in the last 3 months, showing strong buyer reaction. High-volume wicks (e.g., 15% rejection in the 3D candle) combine with Fibonacci 0.618 retracement and EMA50 confluence. Historically, institutional buying has been observed at this OB; a break could trigger $0.1286 downside, with invalidation on a daily close below $0.2325. MTF confluence: 1D/3D support cluster forms a liquidity pool, where big players may be targeting stop hunts.

Secondary Support and Stop Levels

$0.2407 (Strength Score: 63/100): Short-term secondary support, defined as a 1D supply/demand zone; rejected in the last 24 hours at the $0.24 low with volume increase. Forms dynamic support with EMA20 ($0.26), but fragile due to low node in volume profile (low volume area). Invalidation level is an hourly close below $0.2407; this is a liquidity collection point between swing lows with equal lows. Ideal for stop-loss strategies, as a sweep toward $0.2325 is expected.

Resistance Levels: Seller Zones

Near-Term Resistances

$0.2598 (Strength Score: 67/100): The nearest resistance functions as a breaker block (BB) on the 1D timeframe; tested during the last breakout attempt with 5% rejection and high-volume selling pressure. Aligns with the Supertrend bearish signal, reinforcing RSI divergence (lower highs). Why important? Negative volume delta on 3D, positioned above FVG (fair value gap); this is a liquidity target for short positions.

Main Resistance and Targets

$0.29 (Supertrend Resistance) and $0.3364 Upside Target: The main resistance cluster at 1W EMA100 and 3D order block confluence; historical pivot highs (tested 2 times, 10%+ rejection). $0.3364 aligns with Fibonacci 1.272 extension target, but low probability in the downtrend. Breakout invalidation is a daily close above $0.2598; otherwise, pullback to $0.2325 likely. Big sellers are creating imbalance here.

Liquidity Map and Big Players

In the ONDO liquidity map, the $0.2407-$0.2325 area stands out as a major buy-side liquidity pool (stop-loss clusters); price could raid here to clear buyers. Above, $0.2598-$0.29 sell-side liquidity is ideal for breakout fakes. Big players (smart money) may be accumulating positions at 1W order blocks ($0.2325); volume spikes and COT data (institutional longs) support this. In the downtrend, manipulation expected between $0.25 equal highs/lows – look for reversal signals after liquidity grab. MTF 10-level confluence increases manipulation risk.

Bitcoin Correlation

BTC at $68,206 level in downtrend (-1.58%) with Supertrend bearish; altcoins like ONDO under pressure from rising BTC dominance. If BTC supports at $68,086 / $66,388 break, ONDO’s drop to $0.2325 will accelerate in parallel. BTC recovery above $69,552 resistance could carry ONDO to $0.2598. Correlation coefficient 0.85+; if BTC falls to $64,377, ONDO downside to $0.1286 activates – altcoin caution mode active.

Trading Plan and Level-Based Strategy

Bearish bias: Shorts at $0.2598 rejection toward $0.2407-$0.2325 (R/R 1:3, target $0.1286). Bullish scenario: $0.2325 bounce + volume increase for long to $0.2598 (stop below $0.2325). Overall outlook: Selling pressure dominant until support test, invalidation above $0.29. For this level-based view, check ONDO Spot Analysis for spot and ONDO Futures Analysis for futures. Risk management essential: Position size 1-2%, use trailing stops.

This analysis uses the market views and methodology of Chief Analyst Devrim Cacal.

Strategy Analyst: David Kim

Macro market analysis and portfolio management

This analysis is not investment advice. Do your own research.

Source: https://en.coinotag.com/analysis/ondo-technical-analysis-march-23-2026-support-resistance-levels

Opportunità di mercato
Logo Ondo
Valore Ondo (ONDO)
$0.24375
$0.24375$0.24375
-1.97%
USD
Grafico dei prezzi in tempo reale di Ondo (ONDO)
Disclaimer: gli articoli ripubblicati su questo sito provengono da piattaforme pubbliche e sono forniti esclusivamente a scopo informativo. Non riflettono necessariamente le opinioni di MEXC. Tutti i diritti rimangono agli autori originali. Se ritieni che un contenuto violi i diritti di terze parti, contatta crypto.news@mexc.com per la rimozione. MEXC non fornisce alcuna garanzia in merito all'accuratezza, completezza o tempestività del contenuto e non è responsabile per eventuali azioni intraprese sulla base delle informazioni fornite. Il contenuto non costituisce consulenza finanziaria, legale o professionale di altro tipo, né deve essere considerato una raccomandazione o un'approvazione da parte di MEXC.

Potrebbe anche piacerti

Supported by hike speculation and PMIs – Danske Bank

Supported by hike speculation and PMIs – Danske Bank

The post Supported by hike speculation and PMIs – Danske Bank appeared on BitcoinEthereumNews.com. Danske Research Team points out that the Euro was the second-
Condividi
BitcoinEthereumNews2026/03/23 15:59
The geopolitics of anti-corruption as global advisory firms face debarment in the Horn of Africa

The geopolitics of anti-corruption as global advisory firms face debarment in the Horn of Africa

The World Bank’s debarment of PwC and EY for fraud in Ethiopia and Somalia has lifted the veil on the fragility of the Western development model, creating a strategic
Condividi
Theexchange2026/03/23 16:33
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Condividi
BitcoinEthereumNews2025/09/18 03:11